Press release, December 21, 2021 at the 9:00 a.m. (EET)
Shin-Oyama City Hospital in Japan began selling the preventive health service of Nightingale Health Japan KK, a wholly owned subsidiary of Nightingale Health Plc (together “nightingale”), together with Welltus Inc., a subsidiary of the Japanese conglomerate Mitsui & Co. Ltd..
Nightingale’s preventive health service provides unique data on the customer’s current health status and future health risks. The user of the service receives an individual health score and health measurements that describe various health areas, such as heart age, fatty acid balance, inflammation and cholesterol balance. The service also makes recommendations for improving health and wellbeing, and customers can easily track their progress with follow-up tests.
The service as part of. to have Shin-Oyama City Hospital Offer is an important milestone for Nightingale as the commercialization plan is implemented in Japan moves from pilot phase to commercial partnerships. Nightingale and Welltus intend to increase the availability of the service to several hospitals and clinics in. to expand Japan in the first half of 2022.
Teemu Suna, CEO and Co-Founder of Nightingale:
“Shin-Oyama City Hospital is a respected hospital with an established preventive health customer base. We believe that Nightingale’s service will be a valuable addition to Shin-Oyamaâs offering as it provides information about current health and future health risks Actionable recommendations combined. Customers taking action for healthier lives – we can also show the impact of those actions in very powerful ways. ”
DR. Masahiro Nakano, Director of Preventive medical center at the Shin-Oyama City Hospital:
âShin-Oyama City Hospital is delighted to offer Nightingale’s preventive health check-up service, as the service captures key lifestyle-related disease risks from a blood sample and presents health information in an easy-to-understand manner. The Nightingale The health score included in the service is a concrete indicator of overall health and the results show personalized information about which lifestyle changes are worth making to improve health and wellbeing. ”
For more information please contact:
Teemu Suna, CEO
Nightingale health is a health technology company transforming prevention. We envision a world that is about keeping people healthy and not just treating illness. Our far-reaching predictions of disease risk consist of two interrelated factors: our proprietary blood analysis technology and a large amount of data on health events. We help people make better personal health decisions and connect the health industry to offer their services to meet the preventive needs of individuals. By providing the world with comprehensive health insights, we accelerate scientific discovery, industry developments, and improve everyone’s personal health.
About Shin-Oyama City Hospital
Shin-Oyama City Hospital was founded in 1946. Its preventive medical center has set itself the goal of preventing the risk of age-related diseases such as arteriosclerosis and cancer as well as lifestyle-related diseases and, from the point of view of anti-aging medicine, “enjoying a long and healthy life”. And the center offers various medical check-up courses based on the concept of anti-aging of blood vessels.
Mitsui is one of the most diversified and comprehensive trading, investment and service companies in the world with 130 offices in 63 countries (as of September 2021) and sales of $ 72.2 billion away March 2021. Utilizing its global operating locations, network and information resources, Mitsui pursues multilateral businesses ranging from product sales, global logistics and financing to the development of large international infrastructures and other projects in the following areas: wellness, iron and steel products, mineral and metal resources, infrastructure projects, mobility, chemistry, energy, food, food and retail management, IT and communications business, business development. Mitsui actively takes on challenges for global business innovation around the world.
Welltus is a subsidiary founded by Mitsui that provides scientifically sound analyzes and solutions to improve health outcomes. The company leverages Nightingale’s innovative blood testing service and customer-friendly health status visualization to help people change their long-term habits and lead healthier lives. The company also uses Mitsui’s broad network and business portfolio, particularly in the health and wellness sector, to create synergies and quickly expand its service. In April 2021, Welltus and Nightingale announced a service agreement under which the parties will introduce several new health and wellness services Japan. Since June 2021, the first service was tested in a few select medical clinics that sell preventive health checks to consumers.
(c) until 2021. All rights reserved., source Press releases – English